Dr. Daniel Gorelick's lab at Baylor College of Medicine studies how environmental pollutants like dioxins and polycyclic aromatic hydrocarbons (PAHs) affect health by interacting with proteins in our cells. They focus on a specific protein called the aryl hydrocarbon receptor (AHR) that regulates gene expression in response to these toxic substances. By exploring the complexities of AHR signaling, the lab aims to uncover new insights into how these pollutants can lead to diseases, thereby improving our understanding of their impact on human health.

Dr. Thomas A. Cooper's lab at Baylor College of Medicine studies myotonic dystrophy type 1 (DM1), a serious muscle disorder that leads to progressive weakening of skeletal muscles. The lab focuses on understanding how specific genetic mutations disrupt normal muscle function and contribute to the disease. By exploring the roles of certain RNA-binding proteins in muscle development and their connection to the disease, the lab aims to uncover potential therapeutic targets to help manage or treat DM1.

Dr. Bruno Di Stefano's lab focuses on understanding how certain RNA processing mechanisms contribute to the development of acute myeloid leukemia (AML). The research primarily investigates a protein called DDX6, which plays a critical role in regulating RNA within cells, particularly in leukemia. By dissecting these processes, the lab aims to uncover new therapeutic targets and improve treatment strategies for patients with AML.

Dr. Thomas Garcia's lab at Baylor College of Medicine is focused on understanding the genetic causes of male infertility, which is not well understood currently. The research involves using advanced sequencing techniques to identify new genes that influence male fertility. By studying both blood and sperm samples and validating findings in mouse models, the lab aims to shed light on the genetics of infertility and potentially identify targets for new male contraceptive solutions.

Dr. Yi Li's lab focuses on understanding breast cancer risk factors related to childbirth and lactation, as well as developing new rat models to study estrogen receptor-positive breast cancer. They investigate how delaying pregnancy might affect women’s cancer risk, especially with regard to lactation's role in tumor development. Additionally, the lab works on characterizing new animal models to better mimic human breast cancer biology and treatment response.

David M Lonard's research lab focuses on understanding how sex hormones, particularly androgens and progesterone, influence reproductive biology at the molecular level. Using advanced techniques like cryo-electron microscopy, the lab investigates how hormone receptors interact with coregulators and DNA to regulate gene expression. Their work aims to reveal the structural mechanisms behind male and female reproductive processes, potentially addressing issues like infertility and reproductive disorders.

Dr. Diana Monsivais's lab focuses on developing new treatments for endometriosis, a painful condition affecting many women. Their innovative approach seeks to find non-hormonal therapies that can effectively target the disease mechanisms without impacting hormone levels. The lab combines expertise from various fields, including biochemistry and immunology, to create new medications that can help manage this condition more effectively.

Dr. Nagireddy Putluri's research lab at Baylor College of Medicine focuses on understanding bladder cancer, a disease with significant variation in patient outcomes. The lab investigates how genetic alterations, particularly related to a gene called EPHX2, influence tumor behavior and response to treatments. By analyzing molecular and metabolic changes in tumors, they aim to develop new therapeutic strategies that combine targeting cancer metabolism with immunotherapy to improve patient care.

Dr. Martin M. Matzuk's lab at Baylor College of Medicine focuses on innovative areas of reproductive biology, particularly in developing new male contraceptives and therapeutic options for conditions like endometriosis. The lab uses advanced drug discovery techniques to target specific proteins called kinases, which play crucial roles in fertility and reproductive health. By exploring these biological processes, the lab aims to create effective non-hormonal contraceptives and medications that improve women's health outcomes, especially for those suffering from endometriosis.

Dr. Margaret A. Goodell's lab focuses on understanding clonal hematopoiesis (CH), a pre-cancerous condition where certain blood cells expand due to genetic mutations. The lab investigates how different stressors, like inflammation and environmental factors, interact with these mutations to influence the risk of developing blood cancers. By using innovative mouse models and analyzing data from large human studies, their aim is to identify modifiable factors that could prevent the progression of CH into malignancies.

The lab of Dr. Ronald J. Parchem at Baylor College of Medicine focuses on understanding how certain microRNAs influence brain development, particularly in relation to congenital hydrocephalus. By studying the MIR302 family of microRNAs, the lab investigates the timing and regulation of neural stem cell differentiation, which is crucial for proper brain structure formation. This research aims to uncover the molecular mechanisms underlying neurodevelopmental disorders and could lead to new therapeutic approaches for brain malformations.